Newman, Mark
Curran, Desmond A.
Article History
Received: 4 December 2020
Accepted: 3 March 2021
First Online: 15 March 2021
Declarations
:
: The research was conducted on healthy adult volunteers at a commercial testing laboratory. Informed consent was obtained from all participants prior to the study or the National University of Natural Medicine Institutional Review Board determined that written informed consent could be waived for the study population. All data reports were deidentified during extraction so the IRB determined that written informed consent could be waived for this study population. Both studies (Clinical Trials ID: NCT04305093) were approved by the National University of Natural Medicine Institutional Review Board. All methods were performed in accordance with the relevant guidelines and regulations required by both the National University of Natural Medicine Institutional Review Board and CLIA.
: Not applicable.
: Mark Newman is the founder, president, and owner of Preciaion Analytical Inc. Desmond A. Curran is an employee of Precision Analytical. Precision Analytical, Inc. is a commercial laboratory offering hormone testing to medical practitioners and individuals. All statistics were calculated and interpreted by an independent agent.